{"transactions":[{"id":784145,"issuer":{"id":4850,"kind":"organization","name":"Odyssey Therapeutics, Inc."},"owners":[{"id":48240,"kind":"person","name":"Odegard Valerie","position":1,"cik":"0001832432","reported_name":"Odegard Valerie","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-05-12T00:30:16.000Z","date":"2026-05-07","kind":"grant","planned":false,"acquired":true,"shares":27393,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Option will vest in full on May 7, 2027, subject to the Reporting Person's continued service on each such vesting date."}],"balance_after":27393,"derivative":{"exercise_price":18,"expiration_date":"2036-05-06","underlying":"Common Stock","underlying_shares":27393},"source":{"system":"sec-edgar","filing":"0001193125-26-217590","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1832432/000119312526217590/ownership.xml","form_type":"4"}},{"id":2282322,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":48240,"kind":"person","name":"Odegard Valerie","position":1,"cik":"0001832432","reported_name":"Odegard Valerie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CSO"}}],"security":"Stock Option (right to buy)","published_at":"2022-05-04T21:12:32.000Z","date":"2022-05-02","kind":"grant","acquired":true,"shares":90467,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option will vest on May 2, 2023."}],"balance_after":90467,"derivative":{"exercise_price":3.15,"expiration_date":"2032-05-01","underlying":"Common Stock","underlying_shares":90467},"source":{"system":"sec-edgar","filing":"0001209191-22-027158","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919122027158/doc4.xml","form_type":"4"}},{"id":2282321,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":48240,"kind":"person","name":"Odegard Valerie","position":1,"cik":"0001832432","reported_name":"Odegard Valerie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CSO"}}],"security":"Common Stock","published_at":"2022-05-04T21:12:32.000Z","date":"2022-05-02","kind":"grant","acquired":true,"shares":45233,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares being reported are being issued pursuant to restricted stock units, each one of which represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":61639,"source":{"system":"sec-edgar","filing":"0001209191-22-027158","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919122027158/doc4.xml","form_type":"4"}},{"id":2416710,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":48240,"kind":"person","name":"Odegard Valerie","position":1,"cik":"0001832432","reported_name":"Odegard Valerie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CSO"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-02T22:16:05.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":49875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the option vest on February 1, 2023, and the remaining shares will vest monthly thereafter over three years."}],"balance_after":49875,"derivative":{"exercise_price":4.85,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":49875},"source":{"system":"sec-edgar","filing":"0001209191-22-006434","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919122006434/doc4.xml","form_type":"4"}},{"id":2416709,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":48240,"kind":"person","name":"Odegard Valerie","position":1,"cik":"0001832432","reported_name":"Odegard Valerie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CSO"}}],"security":"Stock Option (right to buy)","published_at":"2022-02-02T22:16:05.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":98438,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vest in equal monthly installments over the 48 months following February 1, 2022."}],"balance_after":98438,"derivative":{"exercise_price":4.85,"expiration_date":"2032-01-31","underlying":"Common Stock","underlying_shares":98438},"source":{"system":"sec-edgar","filing":"0001209191-22-006434","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919122006434/doc4.xml","form_type":"4"}},{"id":2416708,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":48240,"kind":"person","name":"Odegard Valerie","position":1,"cik":"0001832432","reported_name":"Odegard Valerie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CSO"}}],"security":"Common Stock","published_at":"2022-02-02T22:16:05.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":16406,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares being reported are being issued pursuant to restricted stock units, each one of which represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":16406,"source":{"system":"sec-edgar","filing":"0001209191-22-006434","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919122006434/doc4.xml","form_type":"4"}},{"id":2955222,"issuer":{"id":883,"kind":"organization","name":"ARS Pharmaceuticals, Inc.","symbol":"SPRY"},"owners":[{"id":48240,"kind":"person","name":"Odegard Valerie","position":1,"cik":"0001832432","reported_name":"Odegard Valerie","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CSO"}}],"security":"Stock Option (right to buy)","published_at":"2020-12-08T01:01:12.000Z","date":"2020-12-03","kind":"grant","acquired":true,"shares":364904,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in equal monthly installments over the 48 months following December 3, 2020."}],"balance_after":364904,"derivative":{"exercise_price":21,"expiration_date":"2030-12-02","underlying":"Common Stock","underlying_shares":364904},"source":{"system":"sec-edgar","filing":"0001209191-20-062054","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671858/000120919120062054/doc4.xml","form_type":"4"}}]}